Janus Henderson Group PLC Cabaletta Bio, Inc. Transaction History

Janus Henderson Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$7.22 - $18.82 $1,285 - $3,349	-178 Reduced 0.91%	19,400 $145,000
Q1 2024 May 15, 2024	BUY	$16.79 - $25.38 $319 - $482	19 Added 0.1%	19,578 $334,000
Q4 2023 Feb 14, 2024	SELL	$12.21 - $23.36 $463 - $887	-38 Reduced 0.19%	19,559 $443,000
Q3 2023 Nov 14, 2023	BUY	$11.84 - $18.65 $232,028 - $365,484	19,597 New	19,597 $298,000

126

47.9M

202K

110K

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $66.4M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.